IDSA: Antibiotics for Seven Days Feasible for Patients Hospitalized With Bloodstream Infections
By Lori Solomon HealthDay Reporter
MONDAY, Oct. 21, 2024 -- Treating hospitalized patients with bloodstream infections with antibiotics for seven days is noninferior to treating for 14 days, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in Los Angeles.
Nick Daneman, M.D., and Rob Fowler, M.D., from the University of Toronto, and colleagues randomly assigned 3,608 hospitalized patients (ward and intensive care unit [ICU]) with bloodstream infections to receive seven- or 14-day (1,814 and 1,794 patients, respectively) antibiotic treatment.
The researchers reported that most infections were community-onset (75.4 percent), followed by hospital-acquired (13.4 percent) and ICU-acquired (11.2 percent). The urinary tract (42.2 percent), abdomen (18.8 percent), lung (13.0 percent), vascular catheters (6.3 percent), and skin or soft tissue (5.2 percent) were the most common bacteremia sources. Ninety-day mortality occurred in 14.5 percent of patients receiving seven-day and in 16.1 percent of patients receiving 14-day treatment, demonstrating noninferiority of shorter duration treatment. Noninferiority was confirmed in a per-protocol analysis (−2.0 percent; 95 percent confidence interval, −4.5 to 0.6). Findings were similar across secondary clinical outcomes and prespecified patient, pathogen, and syndrome subgroups.
"Finding strong evidence that supports shorter antibiotic treatment durations is a top priority to advance antimicrobial stewardship as drug-resistant bacteria are increasingly becoming a public health threat," Daneman said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Onset of Sepsis in First Week of Life Tied to Increased Likelihood of Autism Spectrum Disorder
TUESDAY, June 24, 2025 -- Early-onset neonatal sepsis is associated with increased likelihood autism spectrum disorder (ASD) and of attention-deficit/hyperactivity disorder...
Virtual Reality Training Module May Aid Infection Control Efforts
TUESDAY, June 17, 2025 -- Users report positive experiences and engagement with a virtual reality tool that trains clinicians on core concepts in infection control, including...
Statin Use Linked to Reduced Mortality for Patients With Sepsis
THURSDAY, June 12, 2025 -- For critically ill adults with sepsis, statin use is associated with reduced mortality, according to a study published online June 5 in Frontiers in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.